Identification of one novel candidate probiotic lactobacillus plantarum strain active against influenza virus infection in mice by a large-scale screening

Applied and Environmental Microbiology

Volumn 79, Issue 5, 2013, Pages 1491-1499

  Kechaou, Noura ^a   Chain, Florian ^a   Gratadoux, Jean Jacques ^a   Blugeon, Sébastien ^a   Bertho, Nicolas ^b   Chevalier, Christophe ^b   Le Goffic, Ronan ^b   Courau, Stéphanie ^c   Molimard, Pascal ^c   Chatel, Jean Marc ^a   Langella, Philippe ^a   Bermúdez Humarán, Luis G ^a  

^a UMR1319 MICALIS   (France)

^b INRA Institut National de la Recherche Agronomique   (France)

^c Merck Medication Familiale   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-INFLAMMATORIES; BACTERIAL STRAINS; CELLULAR MODEL; CLINICAL SYMPTOMS; HT-29 CELLS; IMMUNOMODULATORY; IN-VIVO; INFLUENZA VIRUS; INTRAGASTRIC ADMINISTRATION; L. PLANTARUM; LACTIC ACID BACTERIA; LACTOBACILLUS PLANTARUM; MURINE MODEL; PERIPHERAL BLOOD MONONUCLEAR CELLS; PROBIOTIC LACTOBACILLI; PROBIOTIC STRAIN; PROBIOTICS; PROINFLAMMATORY; PROTECTIVE EFFECTS; PUERTO RICO; TUMOR NECROSIS FACTOR ALPHA; WEIGHT LOSS;

BACILLI; DIAGNOSIS; LACTIC ACID; MAMMALS;

VIRUSES;

IMMUNOLOGIC FACTOR; PROBIOTIC AGENT;

GENETIC ANALYSIS; HEALTH STATUS; INFECTIOUS DISEASE; MICROBIAL COMMUNITY; RODENT; VIRUS;

ANIMAL; ARTICLE; BODY WEIGHT; CELL CULTURE; DISEASE MODEL; IMMUNOLOGY; ISOLATION AND PURIFICATION; LACTOBACILLUS PLANTARUM; LUNG; MICROBIOLOGY; MONONUCLEAR CELL; MOUSE; ORTHOMYXOVIRUS; ORTHOMYXOVIRUS INFECTION; PATHOGENICITY; PATHOLOGY; VIROLOGY;

ANIMALS; BODY WEIGHT; CELLS, CULTURED; DISEASE MODELS, ANIMAL; IMMUNOLOGIC FACTORS; LACTOBACILLUS PLANTARUM; LEUKOCYTES, MONONUCLEAR; LUNG; MICE; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; PROBIOTICS;

EID: 84874714746     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.03075-12     Document Type: Article

References (32)

1. Food and Agriculture Organization. 2002. FAO/WHO Working Group report on drafting guidelines for the evaluation of probiotics in food, p 11. Food and Agriculture Organization, London, United Kingdom.
2. van der Aa LB, van Aalderen WM, Heymans HS, Henk Sillevis Smitt J, Nauta AJ, Knippels LM, Ben Amor K, Sprikkelman AB. 2011. Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis. Allergy 66:170 -177.
3. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE. 2006. Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect. Dis. 6:374- 382.
4. Pham LC, Hoogenkamp MA, Exterkate RA, Terefework Z, de Soet JJ, ten Cate JM, Crielaard W, Zaura E. 2011. Effects of Lactobacillus rhamnosus GG on saliva-derived microcosms. Arch. Oral Biol. 56:136 -147.
5. Bermudez-Humaran LG, Kharrat P, Chatel JM, Langella P. 2011. Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines. Microb. Cell Fact. 10(Suppl 1):S4. doi:10.1186 /1475-2859-10-S1-S4.
6. Sorokulova I. 2008. Preclinical testing in the development of probiotics: a regulatory perspective with Bacillus strains as an example. Clin. Infect. Dis. 46(Suppl 2):S92-S95; discussion, S144-S151. doi:10.1086/523334.
7. Endres JR, Clewell A, Jade KA, Farber T, Hauswirth J, Schauss AG. 2009. Safety assessment of a proprietary preparation of a novel probiotic, Bacillus coagulans, as a food ingredient. Food Chem. Toxicol. 47:1231- 1238.
8. Jacobsen CN, Rosenfeldt Nielsen V, Hayford AE, Moller PL, Michaelsen KF, Paerregaard A, Sandstrom B, Tvede M, Jakobsen M. 1999. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl. Environ. Microbiol. 65:4949-4956.
9. Foligne B, Nutten S, Grangette C, Dennin V, Goudercourt D, Poiret S, Dewulf J, Brassart D, Mercenier A, Pot B. 2007. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J. Gastroenterol. 13:236 -243.
10. Annuk H, Shchepetova J, Kullisaar T, Songisepp E, Zilmer M, Mikelsaar M. 2003. Characterization of intestinal lactobacilli as putative probiotic candidates. J. Appl. Microbiol. 94:403- 412.
11. Hori T, Kiyoshima J, Shida K, Yasui H. 2002. Augmentation of cellular immunity and reduction of influenza virus titer in aged mice fed Lactobacillus casei strain Shirota. Clin. Diagn. Lab. Immunol. 9:105-108.
12. Youn HN, Lee DH, Lee YN, Park JK, Yuk SS, Yang SY, Lee HJ, Woo SH, Kim HM, Lee JB, Park SY, Choi IS, Song CS. 2012. Intranasal administration of live Lactobacillus species facilitates protection against influenza virus infection in mice. Antiviral Res. 93:138 -143.
13. Guillemard E, Tondu F, Lacoin F, Schrezenmeir J. 2010. Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br. J. Nutr. 103:58-68.
14. de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, Ott S, Hampe J, Schreiber S, Heller K, Schrezenmeir J. 2006. Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 24:6670-6674.
15. Maeda N, Nakamura R, Hirose Y, Murosaki S, Yamamoto Y, Kase T, Yoshikai Y. 2009. Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice. Int. Immunopharmacol. 9:1122-1125.
16. Boge T, Remigy M, Vaudaine S, Tanguy J, Bourdet-Sicard R, van der Werf S. 2009. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27:5677-5684.
17. Olivares M, Diaz-Ropero MP, Sierra S, Lara-Villoslada F, Fonolla J, Navas M, Rodriguez JM, Xaus J. 2007. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23:254 -260.
18. Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L, Saxelin M, Korpela R. 2001. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322:1327. doi:10.1136/bmj.322.7298.1327.
19. Rautava S, Salminen S, Isolauri E. 2009. Specific probiotics in reducing the risk of acute infections in infancy-a randomised, double-blind, placebo-controlled study. Br. J. Nutr. 101:1722-1726.
20. Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC. 2009. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 124:e172- e179. doi:10.1542/peds.2008-2666.
21. Le Goffic R, Bouguyon E, Chevalier C, Vidic J, Da Costa B, Leymarie O, Bourdieu C, Decamps L, Dhorne-Pollet S, Delmas B. 2010. Influenza A virus protein PB1-F2 exacerbates IFN-beta expression of human respiratory epithelial cells. J. Immunol. 185:4812- 4823.
22. Giovannini M, Agostoni C, Riva E, Salvini F, Ruscitto A, Zuccotti GV, Radaelli G. 2007. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr. Res. 62:215-220.
23. Harata G, He F, Hiruta N, Kawase M, Kubota A, Hiramatsu M, Yausi H. 2010. Intranasal administration of Lactobacillus rhamnosus GG protects mice from H1N1 influenza virus infection by regulating respiratory immune responses. Lett. Appl. Microbiol. 50:597- 602.
24. Kawase M, He F, Kubota A, Harata G, Hiramatsu M. 2010. Oral administration of lactobacilli from human intestinal tract protects mice against influenza virus infection. Lett. Appl. Microbiol. 51:6 -10.
25. Grimoud J, Durand H, de Souza S, Monsan P, Ouarne F, Theodorou V, Roques C. 2010. In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects. Int. J. Food Microbiol. 144:42-50.
26. Preising J, Philippe D, Gleinser M, Wei H, Blum S, Eikmanns BJ, Niess JH, Riedel CU. 2010. Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis. Appl. Environ. Microbiol. 76:3048 -3051.
27. Sanz Y, De Palma G. 2009. Gut microbiota and probiotics in modulation of epithelium and gut-associated lymphoid tissue function. Int. Rev. Immunol. 28:397- 413.
28. Kawase M, He F, Kubota A, Yoda K, Miyazawa K, Hiramatsu M. 2012. Heat-killed Lactobacillus gasseri TMC0356 protects mice against influenza virus infection by stimulating gut and respiratory immune responses. FEMS Immunol. Med. Microbiol. 64:280 -288.
29. Kawashima T, Hayashi K, Kosaka A, Kawashima M, Igarashi T, Tsutsui H, Tsuji NM, Nishimura I, Hayashi T, Obata A. 2011. Lactobacillus plantarum strain YU from fermented foods activates Th1 and protective immune responses. Int. Immunopharmacol. 11:2017-2024.
30. Nagai T, Makino S, Ikegami S, Itoh H, Yamada H. 2011. Effects of oral administration of yogurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 and its exopolysaccharides against influenza virus infection in mice. Int. Immunopharmacol. 11:2246 -2250.
31. Takeda S, Takeshita M, Kikuchi Y, Dashnyam B, Kawahara S, Yoshida H, Watanabe W, Muguruma M, Kurokawa M. 2011. Efficacy of oral administration of heat-killed probiotics from Mongolian dairy products against influenza infection in mice: alleviation of influenza infection by its immunomodulatory activity through intestinal immunity. Int. Immunopharmacol. 11:1976 -1983.
32. Kobayashi N, Saito T, Uematsu T, Kishi K, Toba M, Kohda N, Suzuki T. 2011. Oral administration of heat-killed Lactobacillus pentosus strain b240 augments protection against influenza virus infection in mice. Int. Immunopharmacol. 11:199 -203.